As of June 3, 2025, Genoray Co Ltd (122310.KQ) reports a Gross Margin of 36.96%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Genoray Co Ltd's Gross Margin
Over recent years, Genoray Co Ltd's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 36.96% |
| 2023-12-31 | 38.35% |
| 2022-12-31 | 42.69% |
| 2021-12-31 | 41.72% |
| 2020-12-31 | 42.11% |
This slight downward trend highlights how Genoray Co Ltd manages its operational efficiency and pricing power over time.
Comparing Genoray Co Ltd's Gross Margin to Peers
To better understand Genoray Co Ltd's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Genoray Co Ltd (122310.KQ) | 36.96% |
| InBody Co Ltd (041830.KQ) | 77.39% |
| Solborn Inc (035610.KQ) | 66.92% |
| IntroMedic Co Ltd (150840.KQ) | 65.76% |
| MITech Co Ltd (179290.KQ) | 57.51% |
| Remed Co Ltd (302550.KQ) | 55.47% |
Compared to its competitors, Genoray Co Ltd's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.